home
Menu
Create
Random
0
0
0

Locations of Blood Groups up to Donor Deferrals - Statistics

Jump to: Answer Stats | Score Distribution | Your Scores
General Stats
  • This quiz has been taken 4 times
  • The average score is 12 of 232
Answer Stats
Category Hint Answer % Correct
Location 4th component of C4 Chido/Rodgers
100%
Location AQP1 Colton
100%
Location Band 3 Diego
100%
Location Glycophorin C and/or D Gerbich
100%
Location AQP3 Gill
100%
Location Hematopoietic isoform of CD44 marker Indian
100%
Location CR1 Knops
100%
Location Glycophorin A MN
100%
Location CD147 Ok
100%
Location basigin Ok
100%
Location Glycophorin B S
100%
Location p chromosome X Xg
100%
Detection and ID of Antibodies What does LISS contain making it low ionic? 0.2% sodium chloride
0%
Detection and ID of Antibodies What does LISS contain making it low ionic? 0.2% sodium chloride
0%
Donor Screening Ask the donor to open and close the hand every _______ during collection procedure 10-12 seconds
0%
Detection and ID of Antibodies LISS incubation time 10-15 minutes
0%
Detection and ID of Antibodies PEG incubation time 10-30 minutes
0%
Qualifications in Allogenic Donation CuSO4 specific gravity should be 1.053
0%
Qualifications in Allogenic Donation Standards mandates a maximum of ___ of blood/kg of donor weight for whole blood collection, inclusive of pilot tubes for testing. 10.5 mL
0%
Donor Screening The conversion factor ____ is used to convert grams to milliliters 1.06 g/mL
0%
Detection and ID of Antibodies Centrifugation time of gel technology 10 minutes at 910 rpm
0%
Donor Screening Diversion of at least the first __ of blood into a special diversion pouch can capture skin debris and has been shown to reduce the proportion of platelet components containing viable bacteria. 10 mL (15-20 mL)
0%
Methods for Obtaining Autologous Blood Ratio of replacement for colloids 1:1
0%
Qualifications in Allogenic Donation Weight in pounds 110
0%
Qualifications in Allogenic Donation Range of Hemoglobin as per DOH (Female) 12.5-17.5 g/dL
0%
Qualifications in Allogenic Donation Range of Hemoglobin as per DOH (Male) 13.5-18.5 g/dL
0%
Other deferrals Plavix 14 days
0%
Other deferrals Ticlid 14 days
0%
Detection and ID of Antibodies Incubation time of gel technology 15 minutes
0%
Donor Screening Donations of whole blood where the bleed time exceeded ______ are not suitable for the production of plasma components, platelet products, and cryoprecipitate for direct clinical use 15 minutes
0%
Qualifications in Allogenic Donation Acceptable drop of blood will sink in solution within ______ if Hb concentration is greater than or equal to 12.5 mg/dL 15 seconds
0%
Qualifications in Allogenic Donation Age (DOH) 16-65
0%
Donor Screening Is the gauge number of needle often used for bleeding/donation 16G
0%
Qualifications in Allogenic Donation Age (AABB) 18-65
0%
Qualifications in Allogenic Donation Distance between drop of blood and solution should be 1 cm
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Received clotting factors 1M
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Chicken pox vaccination 1M
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Finasteride (Proscar) 1M
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) German measles (rubella) vaccination 1M
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Isotretinoin (Accutane) for acne 1M
0%
Other deferrals Proscar 1 month
0%
Other deferrals Accutane 1 month
0%
Other deferrals Propecia 1 month
0%
Other deferrals Zontivity 1 month
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Tattoo 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) After Hepa B immunoglobulin administration 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Rape victim 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Received transfusion of blood components, or other human tissues (organ, bone, marrow, or skin graft) 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Experimental medication or unlicensed (experimental) vaccine 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Needle stick injury 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Sexual contact with prostitute, person with AIDS/hepatitis, or hemophiliac, or IV drug user 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Recipient of cornea and dura mater (DOH) 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Major operation including dental surgery 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Female who had sexual contact with a man who ever had sex with another man 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Syphilis or gonorrhea 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Healthcare worker exposed to blood or body fluids 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Ear or body piercing 1Y
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Have been in prison, detention or lockup >72 hours 1Y
0%
Other deferrals Transfusion during pregnancy 1 year
0%
Other deferrals Malaria Deferral: Travelers to endemic areas (AABB) 1 year
0%
Other deferrals Malaria Deferral: Former resident of malaria endemic area, or stayed in malaria endemic area for 6 months or more 1 year
0%
Other deferrals Childbirth (DOH) 1 year or 3 months after weaning
0%
Donor Screening Units in which platelets will be made must be maintained at room temperature _______ until the platelet concentrate has been prepared; 20-24C
0%
Donor Screening Before the needle is removed from the donor’s arm, pilot tubes are filled. The pressure is reduced to __________ 20 mmHg or less
0%
Detection and ID of Antibodies Simulate how Antibody Screening is done 2,1,c,o,p,i,o,w,2,c,o,CCC,o
0%
Other deferrals Feldene 2 days
0%
Other deferrals Aspirin (Book) 2 days
0%
Other deferrals Piroxicam (Book) 2 days
0%
Donor Screening example of sulfhydryl reagents 2-mercaptoethanol
0%
Other deferrals Whole Blood Donation (AABB) 2 months
0%
Detection and ID of Antibodies 22% albumin incubation time 30-60 minutes
0%
Qualifications in Allogenic Donation Volume of the container to be used in CuSO4 method 30 mL
0%
Donor Screening minimum time of scrubbing the site 30 seconds
0%
Methods for Obtaining Autologous Blood Ratio of replacement for crystalloids 3:1
0%
Qualifications in Allogenic Donation Hematocrit of women 38%
0%
Qualifications in Allogenic Donation Hematocrit of men 39%
0%
Methods for Obtaining Autologous Blood The last blood collection should occur no later than __________ before the scheduled surgery to allow for volume replacement. 3 days
0%
Other deferrals Effient 3 days
0%
Other deferrals Aspirin (DOH) 3 days
0%
Other deferrals Piroxicam (DOH) 3 days
0%
Other deferrals HIV Prevention 3 months
0%
Other deferrals PrEP or PEP 3 months
0%
Other deferrals Whole Blood Donation (DOH) 3 months
0%
Other deferrals Soriatane 3 years
0%
Other deferrals Malaria Deferral: Immigrants, refuges, citizens who resided on endemic areas, and diagnosed/infected with malaria (AABB) 3 years
0%
Other deferrals Malaria Deferral: Malaria Infection (DOH) 3 years after treatment, if asymptomatic
0%
Donor Screening apply tourniquet or blood pressure cuff about ____ to increase distention of the vein 40-60 mmHg
0%
Donor Screening Blood withdrawn over a 7-10 time period and mixed with anticoagulant 450 10% (405-495 mL)
0%
Donor Screening Mix blood and anticoagulant periodically every _____ during the procedure 45 seconds
0%
Types of Donation In apheresis, the donor or patient remains attached to the amount of time for a particular procedure can range from 45 to 120 minutes
0%
Donor Screening measurement of scrubbing 4 cm (2x2)
0%
Other deferrals MMR combined (book) 4 weeks
0%
Qualifications in Allogenic Donation Weight in kg 50
0%
Qualifications in Allogenic Donation Pulse as per trans 50-100
0%
Methods for Obtaining Autologous Blood In the 3rd method of obtaining autologous blood, how much is the hematocrit of the residual red cells concentrated into before reinfusing the cells? 50-60%
0%
Detection and ID of Antibodies Measure of gel card 5x7 cm
0%
Detection and ID of Antibodies No. of microtubes consisting the gel card 6
0%
Qualifications in Allogenic Donation Pulse as per DOH 60-100
0%
Qualifications in Allogenic Donation Blood pressure diastolic as per DOH 60-100 mmHg
0%
Donor Screening Volume of anticoagulant in blood bag 63 mL
0%
Donor Screening Blood collected must be processed for component preparation within __ of collection. 6-8 hours
0%
Qualifications in Allogenic Donation General requirement as per DOH 6-8 hrs uninterrupted sleep
0%
Other deferrals Avodart 6 months
0%
Other deferrals Malaria Deferral: Travel to area endemic for malaria with or without prophylaxis (stay for < 6 months) 6 months
0%
Other deferrals Childbirth (AABB) 6 weeks after
0%
Qualifications in Allogenic Donation Regular donors may be accepted up to ___ yrs old (before ___ birthday) subject to evaluation by a medical officer 70; 71st
0%
Detection and ID of Antibodies pH of saline used in washing cell-serum mixture before performing AHG in test tube 7.2-7.4
0%
Other deferrals Brilinta 7 days
0%
Other deferrals MMR combined (DOH) 8 weeks
0%
Qualifications in Allogenic Donation Blood pressure systolic as per DOH 90-160 mmHg
0%
Other deferrals Childbirth (WHO) 9 months after until 3 months after weaning
0%
Types of Donation In autologous donation, what are the minimum tests needed to perform? ABO and Rh
0%
Detection and ID of Antibodies Gel technology applications ABO forward and reverse, Rh typing, DAT, Antibody screening, Antibody identification, Compatibility testing
0%
Donor Screening Common anticoagulant for apheresis ACD
0%
Methods for Obtaining Autologous Blood Results in the collection of whole blood with the concurrent infusion of crystalloid or colloid solutions, thus maintaining a normal blood volume but decreasing the patient’s hematocrit Acute normovolemic hemodilution
0%
Donor Screening process used to physically remove antibodies from sera adsorption
0%
Donor Screening Patient’s history includes age, sex, race, diagnosis, pregnancy, transfusion history, current medications, intravenous solutions
0%
Types of Donation Type of donation: genetically different individual of the same species allogenic donation
0%
Types of Donation Greek word apheresis is derived from aphairos
0%
Location HLA Class 1 on RBC Bennett Good Speed Antigens
0%
Donor Screening Blood is regulated both as a ___ and as a ____ Biologic
0%
Location Erythrocyte acetylcholinesterase Cartwright
0%
Donor Screening Donors who are allergic or sensitive to iodine compounds may use Chlorhexidine gluconate and isopropyl alcohol
0%
Donor Screening Reagent used in antibody identification collection of 11-20 group O RBCs w/ various antigen expression
0%
Location DAF Cromer
0%
Location CD55 Cromer
0%
Detection and ID of Antibodies 22% albumin mechanism decrease zeta potential
0%
Detection and ID of Antibodies Gel used in gel technology dextran-acrylamide gel
0%
Location AE1 Diego
0%
Location SLC4A1 Diego
0%
Types of Donation Type of donation: collected under the same requirements as those for allogeneic donors, except that the unit collected is directed toward a specific patient Directed blood donation
0%
Donor Screening example of sulfhydryl reagents dithiothreitol
0%
Location carried on ART4 by GPI anchor Dombrock
0%
Types of Donation The idea of apheresis was developed by Dr. Edwin J. Cohn
0%
Donor Screening Blood is regulated both as a ___ and as a ____ Drug
0%
Donor Screening harvested antibody-containing fluid eluate
0%
Donor Screening process used to remove antibodies bound to RBCs elution
0%
Types of Donation In the case of autologous donation in which collecting and transfusing facilities are different, how frequent should the unit be tested? every 30-day period
0%
Donor Screening Governing body for blood bank inspection; inspects blood banks every year FDA
0%
Donor Screening If the volume collected is in the low volume range (300 to 404 mL in a 450-mL collection or 333 to 449 mL in a 500-mL collection), the unit must be labeled as a “low volume unit,” and ______ cannot be made from this unit as it would not contain adequate levels of coagulation factors. FFP
0%
Types of Donation In the case of autologous donation in which collecting and transfusing facilities are different, what unit should be tested? first unit
0%
Detection and ID of Antibodies Advantage of test tube method flexibility, availability, cost
0%
Antiglobulin Test Source of error in AHG: Cell suspension either too weak or too heavy FN
0%
Antiglobulin Test Source of error in AHG: Inadequate or improper washing of cells FN
0%
Antiglobulin Test Source of error in AHG: AHG reagent, test serum, or enhancement medium not added FN
0%
Antiglobulin Test Source of error in AHG: AHG reagent nonreactive because of deterioration or neutralization (improper reagent storage) FN
0%
Detection and ID of Antibodies Error if washing of cell-serum mixture is not done before AHG phase FN
0%
Antiglobulin Test Source of error in AHG: Improper specimen (refrigerated, clotted) may cause in vitro complement attachment FP
0%
Antiglobulin Test Source of error in AHG: Bacterial contamination of cells or saline used in washing. FP
0%
Antiglobulin Test Source of error in AHG: Using a serum sample for a DAT FP
0%
Antiglobulin Test Source of error in AHG: Cells with a positive DAT will yield a positive IAT. FP
0%
Detection and ID of Antibodies What does LISS contain that reduces zeta potential? glycine or dextrose (glucose)
0%
Qualifications in Allogenic Donation General appearance good health
0%
General Requirements for Autologous Donation Hemoglobin greater than or equal to 11 g/dL
0%
Qualifications in Allogenic Donation Hemoglobin as per AABB (Female) greater than or equal to 12.5 g/dL
0%
Qualifications in Allogenic Donation Hemoglobin as per AABB (Male) greater than or equal to 13.0 g/dL
0%
General Requirements for Autologous Donation Hematocrit greater than or equal to 33%
0%
Types of Donation Autologous units color Green
0%
Qualifications in Allogenic Donation donor age that needs physician consent >65
0%
Detection and ID of Antibodies Principle of gel technology Hemagglutination
0%
Detection and ID of Antibodies Antibody class capable of causing agglutination of saline-suspended RBCs IgM
0%
Donor Deferral Prospective donor is unable to donate blood for someone else for an unspecified period of time due to current regulatory requirements. Indefinite
0%
Donor Deferral This donor would not be able to donate blood until the current requirement changes. Indefinite
0%
Methods for Obtaining Autologous Blood Involves collecting shed blood from the surgical site; processing the blood through an instrument that washes it with saline to remove tissue debris, free hemoglobin, and plasma that may contain activated coagulation factors; concentrating the residual red cells (to a hematocrit of 50% to 60%); and then reinfusing those cells immediately. Intraoperative collection
0%
Location Semaphorin 7A JMH
0%
Location CD108 JMH
0%
Detection and ID of Antibodies Mixed-field gel reaction Layer of red cell agglutinates at the top of the gel column accompanied by a pellet of unagglutinated cells in the bottom of the microtube
0%
Qualifications in Allogenic Donation Pulse of an athletic — not a cause for deferral less than 50
0%
Qualifications in Allogenic Donation Blood pressure systolic as per AABB less than or equal to 180 mmHg
0%
Qualifications in Allogenic Donation Temperature in celcius less than or equal to 37.5
0%
Qualifications in Allogenic Donation Temperature in fahrenheit less than or equal to 99.5
0%
Qualifications in Allogenic Donation Blood pressure diastolic as per AABB less than pr equal to 100 mmHg
0%
Detection and ID of Antibodies Screening and panel cells are suspended in what solution LISS
0%
Detection and ID of Antibodies LISS mechanism lower zeta potential and decrease ionic cloud increasing antibody uptake by RBCs
0%
Other deferrals 2 weeks referral due to vaccination Measles
0%
Other deferrals 2 weeks referral due to vaccination Mumps
0%
Other deferrals Is abortion in 1st trimester or 2nd trimester a cause for deferral? No
0%
Qualifications in Allogenic Donation General requirement as per DOH no alcohol (24 hours)
0%
Qualifications in Allogenic Donation General appearance no intake of alcohol
0%
Qualifications in Allogenic Donation General appearance no intake of drugs
0%
General Requirements for Autologous Donation Age None
0%
General Requirements for Autologous Donation Weight None
0%
Other deferrals Toxoid/killed/synthetic vaccines None
0%
Qualifications in Allogenic Donation General appearance no skin lesions
0%
Qualifications in Allogenic Donation General requirement as per DOH no smoking (4 hours)
0%
General Requirements for Autologous Donation Frequency not more than 3 days
0%
Detection and ID of Antibodies Describe Coomb’s check cells O+ coated with anti-D
0%
Other deferrals 2 weeks referral due to vaccination Oral polio
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Positive for AIDS P1
0%
Qualifications in Allogenic Donation needed document of a 16-17 year old donor parental consent
0%
Antiglobulin Test is an important technical aspect in the performance of an antiglobulin test. Patent blue and ariavit tartrazine
0%
Detection and ID of Antibodies Most sensitive among all potentiators PEG
0%
Donor Deferral Prospective donor will never be eligible to donate blood for someone else. Permanent
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Chronic cardiopulmonary disease PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Positive for HTLV PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Leukemia, lymphoma, or myeloproliferative disorder PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Recipient of human pituitary—derived growth hormone PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Recipient of bovine insulin PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Renal disease (chronic) PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) IV drug user PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Recipient of cornea and dura mater (trans) PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Positive for HBsAg PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) History of babesiosis PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) History of Chagas disease PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Etretinate (Tegison’ treatment for psoriasis PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Malignant solid tumors PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Liver disease (chronic) PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Rabies vaccination PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Hemophiliacs PI
0%
Identify: Permanent/Indefinite (PI), 1 year (1Y), 1 month (1M) Tegison PI
0%
Types of Donation First product to be collected by apheresis methods Plasma
0%
Donor Screening For blood collection, most blood centers use an iodine compound such as ____ (2) polymer iodine complex
0%
Methods for Obtaining Autologous Blood a drainage tube is placed in the surgical site and postoperative bleeding is salvaged, cleaned and reinfused Postoperative blood salvage
0%
Methods for Obtaining Autologous Blood Occurs during the 5 to 6 weeks immediately preceding a scheduled, elective surgical procedure unless the red blood cells and plasma are scheduled to be frozen. Postoperative Collection
0%
Detection and ID of Antibodies 3+ gel reaction Predominant amount of agglutinated red cells at the top of the gel column with a few agglutinates staggered below the thicker band.
0%
Donor Screening For blood collection, most blood centers use an iodine compound such as ____ (1) PVP iodine
0%
Location CD151 Raph
0%
Detection and ID of Antibodies 2+ gel reaction Red cell agglutinates are dispersed throughout the gel column with few agglutinates at the bottom of the microtube.
0%
Detection and ID of Antibodies 1+ gel reaction Red cell agglutinates predominantly observed in the lower half of the gel column with red cells also in the bottom
0%
Detection and ID of Antibodies Negative gel reaction Red cells forming a well-delineated pellet in the bottom of the microtube. The gel above the red cell pellet is clear and free of agglutinates
0%
Detection and ID of Antibodies PEG mechanism removes water from the test system
0%
Location Chromosome 6 RHAG
0%
Detection and ID of Antibodies 4+ gel reaction Solid band of agglutinated red cells at the top of the gel column. Usually no red cells are visible in the bottom of the microtube.
0%
Detection and ID of Antibodies Disadvantage of gel technology and solid phase technology method specialized instrument or equipment
0%
Detection and ID of Antibodies Advantage of gel technology and solid phase technology method standardization
0%
Detection and ID of Antibodies Disadvantage of test tube method subjective
0%
Donor Screening Destroys the pentameric structure of agglutinating IGM sulfhydryl reagents
0%
Donor Deferral Prospective donor is unable to donate blood for a limited period of time. Temporary
0%
Other deferrals 2 weeks referral due to vaccination Typhoid
0%
Types of Donation What is required to be tested if collecting and transfusing facilities are the same? viral markers and STS
0%
Other deferrals 2 weeks referral due to vaccination Yellow fever
0%
Types of Donation Directed blood donation color yellow, salmon
0%
No matching quizzes found
Score Distribution
Percent of People with Each Score
Percentile by Number Answered
Your Score History
You have not taken this quiz
Copyright H Brothers Inc, 2008–2026
Contact Us | Go To Top | View Mobile Site | Site Map